- Home
- WNW vs XCUR Comparison
WNW vs XCUR Comparison
Compare WNW & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- XCUR
- Stock Information
- Founded
- WNW 2015
- XCUR 2011
- Country
- WNW China
- XCUR United States
- Employees
- WNW N/A
- XCUR N/A
- Industry
- WNW Catalog/Specialty Distribution
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- XCUR Health Care
- Exchange
- WNW Nasdaq
- XCUR Nasdaq
- Market Cap
- WNW 26.6M
- XCUR 29.4M
- IPO Year
- WNW 2020
- XCUR N/A
- Fundamental
- Price
- WNW $1.71
- XCUR $4.46
- Analyst Decision
- WNW
- XCUR
- Analyst Count
- WNW 0
- XCUR 0
- Target Price
- WNW N/A
- XCUR N/A
- AVG Volume (30 Days)
- WNW 17.0K
- XCUR 39.7K
- Earning Date
- WNW 11-14-2025
- XCUR 11-13-2025
- Dividend Yield
- WNW N/A
- XCUR N/A
- EPS Growth
- WNW N/A
- XCUR N/A
- EPS
- WNW 9.06
- XCUR N/A
- Revenue
- WNW $158,485.00
- XCUR N/A
- Revenue This Year
- WNW N/A
- XCUR N/A
- Revenue Next Year
- WNW N/A
- XCUR N/A
- P/E Ratio
- WNW $0.19
- XCUR N/A
- Revenue Growth
- WNW N/A
- XCUR N/A
- 52 Week Low
- WNW $0.95
- XCUR $2.44
- 52 Week High
- WNW $70.00
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- WNW 39.54
- XCUR 45.98
- Support Level
- WNW $1.62
- XCUR $4.52
- Resistance Level
- WNW $1.87
- XCUR $5.26
- Average True Range (ATR)
- WNW 0.13
- XCUR 0.46
- MACD
- WNW -0.02
- XCUR -0.01
- Stochastic Oscillator
- WNW 21.13
- XCUR 6.29
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.